Free Trial

International Biotechnology (LON:IBT) Stock Crosses Above 200 Day Moving Average - What's Next?

International Biotechnology logo with Financial Services background

Key Points

  • International Biotechnology's stock price recently surpassed its 200-day moving average, indicating potential increased momentum in its trading performance.
  • The current stock price is at GBX 674 ($9.20), above the 200-day moving average of GBX 616.85 ($8.42), with a market cap of £227.56 million.
  • The company aims for long-term capital growth by investing in a diversified portfolio of biotechnology and life sciences companies with strong growth prospects.
  • MarketBeat previews the top five stocks to own by October 1st.

International Biotechnology (LON:IBT - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 616.85 ($8.31) and traded as high as GBX 680 ($9.16). International Biotechnology shares last traded at GBX 674 ($9.08), with a volume of 58,672 shares.

International Biotechnology Stock Performance

The stock's fifty day moving average price is GBX 665.60 and its 200-day moving average price is GBX 617.37. The company has a market capitalization of £237.94 million, a P/E ratio of 1,460.49 and a beta of 0.21.

International Biotechnology Company Profile

(Get Free Report)

The Company's investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.

Further Reading

Should You Invest $1,000 in International Biotechnology Right Now?

Before you consider International Biotechnology, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and International Biotechnology wasn't on the list.

While International Biotechnology currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.